Shire PLC and Genentech Inc. have both gone to the hemophilia community to argue their position in litigation over Hemlibra (emicizumab-kxwh), but patient advocacy groups are declining to take sides in the dispute.
Shire subsidiary Baxalta Inc. filed a motion on Dec. 14 seeking a preliminary injunction to prevent Genentech, a unit...





